Apitoria Pharma Pvt Ltd gets Form 483 with 10 observations from US FDA

The United States Food and Drug Administration (US FDA) inspected Unit-II, an API manufacturing facility, of Apitoria Pharma Private Limited, a wholly owned subsidiary of AUROBINDO PHARMA LIMITED, situated at Gaddapotharam Village IDA, Jinnaram Mandal, Sanga Reddy District, Telangana from September 23 to 27, 2024.

The inspection closed with 10 observations. The observations are of procedural in nature and will be responded to within the stipulated time.

The US FDA audit concluded on Friday, September 27, 2024 at 8.00 PM. Because of non-availability of senior technical team to review the nature of observations, there is a delay in intimation.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1460.90 as compared to the previous close of Rs. 1509.75. The total number of shares traded during the day was 31711 in over 3859 trades.

The stock hit an intraday high of Rs. 1516.65 and intraday low of 1443.50. The net turnover during the day was Rs. 46739297.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 ApitoriaPharma USFDA Inspection Unit2 APIFacility Form483 10Observations